ObjectiveThis study aimed to investigate the protective effects of baicalin on
myocardial infarction in rats and explore the related mechanisms.MethodsFifty Sprague Dawley rats were randomly divided into the control, model, and
low-, medium- and high-dose baicalin groups. The latter 3 groups were
intraperitoneally injected with baicalin, with a dose of 12.5, 25 and 50
mg/kg, respectively. Then, the myocardial infarction model was established.
The hemodynamic of rats was tested, the serum lactate dehydrogenase (LDH),
creatine kinase-MB (CK-MB), prostacyclin (PGI2) and thromboxane
A2 (TXA2) were determined, the myocardial
superoxide dismutase (SOD) and malondialdehyde (MDA) levels were detected,
and the myocardial B-cell lymphoma-2 (Bcl-2) and Bcl-2 associated X (Bax)
protein expressions were determined.ResultsCompared with the model group, in the high-dose baicalin group the ST segment
height and LVEDP were significantly decreased (P<0.05),
the LVSP was significantly increased (P<0.05), the serum
LDH, CK-MB and TXA2 levels were significantly decreased
(P<0.05), the PGI2 level was significantly
increased (P<0.05), the myocardial SOD level was
significantly increased (P<0.05), and the myocardial MDA
level was significantly decreased (P<0.05); the
myocardial Bcl-2 protein level was significantly increased, and the Bax
protein level was significantly decreased (P<0.05).ConclusionBaicalin has protective effects on myocardial infarction in rats. The
possible mechanisms may be related to its resistance to oxidative stress,
and up-regulation of Bcl-2 protein expression and down-regulation of Bax
protein expression in myocardial tissue.